Yozo Todo

525 total citations
26 papers, 416 citations indexed

About

Yozo Todo is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Yozo Todo has authored 26 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 15 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Yozo Todo's work include Cancer therapeutics and mechanisms (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Synthesis and Biological Evaluation (8 papers). Yozo Todo is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Synthesis and Biological Evaluation (8 papers). Yozo Todo collaborates with scholars based in Japan. Yozo Todo's co-authors include Hirokazu Narita, Masahiro Takahata, Junichi Mitsuyama, Yasuo Watanabe, Shinzaburo Minami, Minoru Yonezawa, Nobuhiko Nomura, Akiko Kimura, Hiroshi Nishikawa and Kyoko Hashimoto and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and The Journal of Antibiotics.

In The Last Decade

Yozo Todo

24 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yozo Todo Japan 9 180 175 138 100 85 26 416
G. Beskid United States 16 111 0.6× 219 1.3× 81 0.6× 184 1.8× 186 2.2× 35 531
DEBORAH L. MULLEN United States 11 98 0.5× 212 1.2× 240 1.7× 110 1.1× 280 3.3× 15 687
Katherine E. Brighty United States 8 88 0.5× 197 1.1× 42 0.3× 127 1.3× 153 1.8× 14 417
William J. Novick United States 13 165 0.9× 175 1.0× 145 1.1× 187 1.9× 144 1.7× 23 708
Jicheng Yu China 15 189 1.1× 336 1.9× 143 1.0× 172 1.7× 68 0.8× 54 543
T. H. Farmer United Kingdom 11 78 0.4× 93 0.5× 59 0.4× 152 1.5× 144 1.7× 18 389
Monica Abbondi Italy 10 44 0.2× 132 0.8× 118 0.9× 41 0.4× 192 2.3× 12 371
David A Yurek United States 12 44 0.2× 99 0.6× 71 0.5× 44 0.4× 201 2.4× 23 448
Virna Schuck United States 12 170 0.9× 302 1.7× 40 0.3× 311 3.1× 165 1.9× 17 591
Martin S. Linsell United States 11 82 0.5× 193 1.1× 136 1.0× 218 2.2× 254 3.0× 11 594

Countries citing papers authored by Yozo Todo

Since Specialization
Citations

This map shows the geographic impact of Yozo Todo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yozo Todo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yozo Todo more than expected).

Fields of papers citing papers by Yozo Todo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yozo Todo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yozo Todo. The network helps show where Yozo Todo may publish in the future.

Co-authorship network of co-authors of Yozo Todo

This figure shows the co-authorship network connecting the top 25 collaborators of Yozo Todo. A scholar is included among the top collaborators of Yozo Todo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yozo Todo. Yozo Todo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mitsuyama, Junichi, Nobuhiko Nomura, Kyoko Hashimoto, et al.. (2008). In Vitro and In Vivo Antifungal Activities of T-2307, a Novel Arylamidine. Antimicrobial Agents and Chemotherapy. 52(4). 1318–1324. 93 indexed citations
3.
Takahata, Masahiro, Yoshiko Fukuda, Yuko Ito, et al.. (2007). In vitro antibacterial activity of garenoxacin. 55. 1–20. 9 indexed citations
5.
Takahata, Masahiro, Hiroshi Yamada, Shinzaburo Minami, et al.. (2002). Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits. Antimicrobial Agents and Chemotherapy. 46(6). 1760–1765. 2 indexed citations
6.
Takahata, Masahiro, Junichi Mitsuyama, Minoru Yonezawa, et al.. (1999). In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-Quinolone. Antimicrobial Agents and Chemotherapy. 43(5). 1077–1084. 128 indexed citations
8.
Mitsuyama, Junichi, Hiroshi Yamada, Yasumichi Fukuda, et al.. (1997). Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 39(6). 697–705. 20 indexed citations
9.
Ono, Satoshi, et al.. (1995). Studies on Cognitive Enhancing Agents. II. Antiamnestic and Antihypoxic Activities of 1-Aryl-2-(2-aminoethoxy)ethanols.. Chemical and Pharmaceutical Bulletin. 43(9). 1488–1491. 1 indexed citations
12.
Ono, Satoshi, et al.. (1995). Studies on Cognitive Enhancing Agents. I. Antiamnestic and Antihypoxic Activities of 2-Dimethylaminoethyl Ethers and Related Compounds.. Chemical and Pharmaceutical Bulletin. 43(9). 1483–1487. 2 indexed citations
17.
Todo, Yozo, et al.. (1994). Practical Synthesis of T-3761, (S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid.. Chemical and Pharmaceutical Bulletin. 42(12). 2629–2632. 4 indexed citations
18.
Ikeda, Yasushi, et al.. (1993). In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrobial Agents and Chemotherapy. 37(3). 384–392. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026